Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare s Revenues Jump 30 Percent; Increase in Orders Driven By Biosciences Products

NEW YORK, Jan. 21 (GenomeWeb News) - GE Healthcare saw its revenues jump by almost 30 percent during the fourth quarter of 2004, contributing $4.3 billion, or about 10 percent, to GE's total revenues. Healthcare's revenues were $3.3 billion during the same quarter a year ago.

 

GE Healthcare's profits also increased steeply, to $860 million, up from $572 million during the same quarter in 2003. These profits accounted for about 13 percent of GE's total profits for the quarter.

 

GE said that orders for Healthcare products and services increased by 25 percent to $4.4 billion during the quarter, compared to the same period in 2003. The Biosciences unit, which used to be Amersham and was not part of GE in 2003, contributed $800 million to the overall orders, meaning that former Amersham contributed approximately 90 percent to the 25 percent increase in orders.

 

For the last quarter of 2003, Amersham reported £451 million ($859 million) in sales.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.